Abiopharma

🔍 Jeldi Arun (Executive)

Company: Velo3D, Inc. (VELO)

Report Date: 2026-06-29

Detailed Transactions and Holdings:

• Acquired 964,474 shares of Stock Option (right to buy) at $18.4 per share (Derivative)
  Date: 2026-06-29 | Code: A | Expires: 2036-06-29 | equity_swap_involved: false | shares_owned_after: 964,474.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: On June 29, 2026, Arun Jeldi was granted an option to purchase 964,474 shares of common stock ("Shares") of Velo3D, Inc. (the "Company"). The option will vest based on the achievement of the following milestones within five years following the grant date: (i) the option will vest with respect to 10% of the Shares subject thereto when the "market capitalization" (as defined in the award agreement) reaches $1 billion; (ii) the option will vest with respect to an additional 20% of the Shares subject thereto when the market capitalization reaches $3 billion; (iii) the option will vest with respect to an additional 30% of the Shares subject thereto when the market capitalization reaches $5 billion; and (iv) the option will vest with respect to the final 40% of the Shares subject thereto when the market capitalization reaches $10 billion, provided in each case that Mr. Jeldi remains in service with the Company through the achievement of the applicable milestone.